Freuer Dennis, Linseisen Jakob, Schmitz Timo, Thorand Barbara, Peters Annette, Petrera Agnese, Heier Margit, Meisinger Christa
Epidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Commun Med (Lond). 2025 Sep 11;5(1):387. doi: 10.1038/s43856-025-01124-x.
Besides their lipid lowering effects, statins exhibit numerous beneficial and adverse effects (so called pleiotropic effects). A major pleiotropic effect of statins is their anti-inflammatory properties, but the impact on a wide range of inflammation-related proteins involved in specific metabolic pathways remains inconclusive. Therefore, in this study we examined the association between statin use and numerous circulating levels of inflammation-related proteins using data from two independent population-based studies.
The association between statin intake and up to 90 inflammation-related proteins (Olink Proteomics) were investigated in 803 and 1008 participants of the KORA-Fit and KORA-Age1 studies, respectively (overall age range: 53-93 years, 52% women). Association-specific multivariable parametric as well as non-parametric regression models were performed to obtain robust estimates. Confounding factors were selected using directed acyclic graphs and the potential effect of unmeasured confounding was assessed.
After adjustment for multiple testing, 3 and 8 associations remain in the KORA-Fit and KORA-Age1 studies, respectively. The strongest evidence (in terms of effect size, replication, and robustness) is found for the positive associations with the inflammation-related proteins TRANS ( = 0.21; 95% CI = [0.08; 0.33]; = 0.035, = 0.13; 95% CI = [0.05; 0.21]; = 0.019) and TRAIL ( = 0.09; 95% CI = [0.03; 0.15]; = 0.045, = 0.09; 95% CI = [0.05; 0.13]; = ) and the negative association with SCF ( = 0.11; 95% CI = [-0.19; -0.03]; = 0.121, = -0.11; 95% CI = [-0.17; -0.06]; = 0.003). Further associations with NT-3, MMP-10, uPA, and CD244 found in one of the studies are consistent with the point estimates of the other study.
The present study identifies associations between statin intake and inflammation-related proteins pointing to certain metabolic pathways. The results could contribute to a better understanding of the mechanisms underlying the pleiotropic effect of statins.
他汀类药物除具有降脂作用外,还表现出众多有益和有害作用(即所谓的多效性作用)。他汀类药物的一个主要多效性作用是其抗炎特性,但对参与特定代谢途径的多种炎症相关蛋白的影响仍不明确。因此,在本研究中,我们使用两项独立的基于人群的研究数据,检验了他汀类药物使用与多种循环炎症相关蛋白水平之间的关联。
分别在KORA-Fit研究的803名参与者和KORA-Age1研究的1008名参与者中(总体年龄范围:53 - 93岁,52%为女性),研究他汀类药物摄入量与多达90种炎症相关蛋白(Olink蛋白质组学)之间的关联。进行了特定关联的多变量参数和非参数回归模型,以获得可靠的估计值。使用有向无环图选择混杂因素,并评估未测量混杂因素的潜在影响。
在进行多重检验校正后,KORA-Fit研究和KORA-Age1研究分别有3种和8种关联存在。与炎症相关蛋白TRANS(效应量 = 0.21;95%置信区间 = [0.08;0.33];P = 0.035,效应量 = 0.13;95%置信区间 = [0.05;0.21];P = 0.019)和TRAIL(效应量 = 0.09;95%置信区间 = [0.03;0.15];P = 0.045,效应量 = 0.09;95%置信区间 = [0.05;0.13];P = )的正相关以及与SCF的负相关(效应量 = 0.11;95%置信区间 = [-0.19;-0.03];P = 0.121,效应量 = -0.11;95%置信区间 = [-0.17;-0.06];P = 0.003)是最强的证据(就效应大小、重复性和稳健性而言)。在其中一项研究中发现的与NT - 3、MMP - 10、uPA和CD244的进一步关联与另一项研究的点估计值一致。
本研究确定了他汀类药物摄入量与指向某些代谢途径的炎症相关蛋白之间的关联。这些结果可能有助于更好地理解他汀类药物多效性作用的潜在机制。